A basket full of targeted therapies
Prof Eric Winer - Dana-Farber Cancer Institute, Boston, USA
A basket full of targeted therapies ( Prof Eric Winer - Dana-Farber Cancer Institute, Boston, USA )
15 Jul 2009
Proton beam radiotherapy for breast cancer
Prof Alphonse Taghian - Massachusetts General Hospital, Boston, USA
Proton beam radiotherapy for breast cancer ( Prof Alphonse Taghian - Massachusetts General Hospital, Boston, USA )
15 Jul 2009
Endocrine treatment for prevention of breast cancer
Dr Andrea Decensi - Galliera Hospital, Genoa, Italy
Endocrine treatment for prevention of breast cancer ( Dr Andrea Decensi - Galliera Hospital, Genoa, Italy )
15 Jul 2009
Breast cancer prevention targets
Dr Karen Johnson - National Cancer Institute, USA
Breast cancer prevention targets ( Dr Karen Johnson - National Cancer Institute, USA )
15 Jul 2009
Genetic determinants for breast cancer spread
Dr Kent Hunter - National Cancer Institute, Bethesda, USA
Genetic determinants for breast cancer spread ( Dr Kent Hunter - National Cancer Institute, Bethesda, USA )
8 Jul 2009
MicroRNAs regulating cancer stem cell self renewal
Dr Michael Clarke - Stanford School of Medicine, USA
MicroRNAs regulating cancer stem cell self renewal ( Dr Michael Clarke - Stanford School of Medicine, USA )
8 Jul 2009
Study of the extra cellular matrix around cancer cells and 3D assays
Dr Mina Bissell - Lawrence Berkeley National Laboratory, USA
Study of the extra cellular matrix around cancer cells and 3D assays ( Dr Mina Bissell - Lawrence Berkeley National Laboratory, USA )
8 Jul 2009
Targeting death receptors in chemo-resistant cancer cells
Prof Patrick Johnston - Queen's University Belfast, UK
Targeting death receptors in chemo-resistant cancer cells ( Prof Patrick Johnston - Queen's University Belfast, UK )
3 Jul 2009
Olaparib induces tumour response as single agent in BRCA-deficient breast cancer
Dr Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London,...
Olaparib induces tumour response as single agent in BRCA-deficient breast cancer ( Dr Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London, UK )
3 Jul 2009
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast c...
Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer ( Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US )
3 Jul 2009
PARP inhibitors show promise for hard-to-treat breast cancers
Dr. Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London...
PARP inhibitors show promise for hard-to-treat breast cancers ( Dr. Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London, UK )
25 Jun 2009
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients ( Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland )
25 Jun 2009